NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
051 St Göran

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 358 5.0% 90 1.3% 19 0.3% . . 1 0.0% 3 0.0% 6634 93.4% 7105 100.0%
ASCUS 157 32.2% 104 21.3% 63 12.9% . . . . 1 0.2% 163 33.4% 488 100.0%
LSIL 123 30.1% 108 26.4% 71 17.4% . . . . . . 107 26.2% 409 100.0%
Atypical glandular cells/AGC 1 100.0% . . . . . . . . . . . . 1 100.0%
Unclear atypia 3 42.9% 1 14.3% 1 14.3% . . 1 14.3% . . 1 14.3% 7 100.0%
ASC-H 12 18.5% 15 23.1% 34 52.3% 1 1.5% 1 1.5% . . 2 3.1% 65 100.0%
HSIL 6 6.1% 10 10.2% 73 74.5% 2 2.0% 5 5.1% . . 2 2.0% 98 100.0%
Suspected Adenocarcinom . . . . . . . . . . . . 2 100.0% 2 100.0%
Squamous cell cancer . . . . . . . . 1 100.0% . . . . 1 100.0%
Totalt 660 8.1% 328 4.0% 261 3.2% 3 0.0% 9 0.1% 4 0.0% 6911 84.5% 8176 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the
category Cancer:
M80703, M81403